相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Cannabinoid Receptor CB2 Exerts Antifibrotic Effects in Experimental Dermal Fibrosis
Alfiya Akhmetshina et al.
ARTHRITIS AND RHEUMATISM (2009)
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
Alfiya Akhmetshina et al.
FASEB JOURNAL (2008)
Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
Christoph W. Michalski et al.
PLOS ONE (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species
Soeren V. Siegmund et al.
FASEB JOURNAL (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis
Roxana Sfrent-Cornateanu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Adenosine A2A receptors in diffuse dermal fibrosis pathogenic role in human dermal fibroblasts and in a murine model of scleroderma
E. S. L. Chan et al.
ARTHRITIS AND RHEUMATISM (2006)
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin
Amol M. Patwardhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice
Randle M. Gallucci et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Receptor-independent effects of endocannabinoids on ion channels
M Oz
CURRENT PHARMACEUTICAL DESIGN (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Matrix contraction by dermal fibroblasts requires transforming growth factor-β/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK -: Insights into pathological scarring in chronic fibrotic disease
YL Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2 - Amplification of ROS and Ras in systemic sclerosis fibroblasts
S Svegliati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anandamide induces necrosis in primary hepatic stellate cells
SV Siegmund et al.
HEPATOLOGY (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Opposing effects of protein kinase Cα and protein kinase Cε on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling
E Tourkina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein
A Ellert-Miklaszewska et al.
CELLULAR SIGNALLING (2005)
Prospects for cannabinoids as anti-inflammatory agents
RB Zurier
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis
S Sato et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2001)
The endocannabinoid system as a target for therapeutic drugs
D Piomelli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
分享论文
